Correlation Between Akero Therapeutics and Bionomics
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Bionomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Bionomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Bionomics Ltd ADR, you can compare the effects of market volatilities on Akero Therapeutics and Bionomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Bionomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Bionomics.
Diversification Opportunities for Akero Therapeutics and Bionomics
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Akero and Bionomics is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Bionomics Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionomics ADR and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Bionomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionomics ADR has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Bionomics go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Bionomics
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 2.57 times less return on investment than Bionomics. But when comparing it to its historical volatility, Akero Therapeutics is 3.4 times less risky than Bionomics. It trades about 0.01 of its potential returns per unit of risk. Bionomics Ltd ADR is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 420.00 in Bionomics Ltd ADR on August 27, 2024 and sell it today you would lose (391.00) from holding Bionomics Ltd ADR or give up 93.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Bionomics Ltd ADR
Performance |
| Timeline |
| Akero Therapeutics |
| Bionomics ADR |
Akero Therapeutics and Bionomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Bionomics
The main advantage of trading using opposite Akero Therapeutics and Bionomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Bionomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will offset losses from the drop in Bionomics' long position.| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
| Bionomics vs. Accustem Sciences | Bionomics vs. Scisparc | Bionomics vs. Anebulo Pharmaceuticals | Bionomics vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |